Scaling Biotech
Jesse JohnsonExploring how processes within drug discovery are changing to take advantage of new models and technology.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 282 | Founded | 6 years ago | Last Issue | 6 days ago |
| Active | |||||
Read this Newsletter
scalingbiotech.substack.comLatest Issues
Who writes the playbook for new technology?
One of the things that makes the most recent wave of digital models for biopharma different is that they’re increasingly coming into drug discovery teams via external companies, as opposed to previous waves that were mostly developed intern...
Between internal and external technology
Last week, I asked the question whether it’s possible for biopharma to adopt new digital technology that’s introduced from the outside, as opposed to the more common historical pattern of internal teams developing their own tools. I failed...
Does AI in biotech have to come from internal teams?
To start answering the question I raised last week about what factors are slowing down tech adoption in biotech, I started looking at the history of how older technologies have been adopted by the industry. One clear pattern is that many of...
The problem(s) with tech in bioteh
As I’ve been shifting my consulting work more towards process change and tech adoption, it’s got me thinking about all the different reasons (or maybe excuses) that could explain why early stage drug discovery seems to have lagged behind ot...
GSK goes deeper on Virtual Cell Models
Just six months after announcing a $50M collaboration giving them access to NOETIK’s virtual cell models, GSK recently announced that they’re expanding their partnership with Relation Therapeutics with a $110M deal to generate perturbationa...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Scaling Biotech.
| Subscribers | Engagement | 68 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Founder of Merelogic
Social
Frequently Asked Questions
How can I access the email archive for Scaling Biotech?
You can find recent issues that have been published by Scaling Biotech on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Scaling Biotech have?
To see how many people subscribe to Scaling Biotech, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Scaling Biotech?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Scaling Biotech as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Scaling Biotech?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Scaling Biotech using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Scaling Biotech?
Scroll up to where it says Related Newsletters to see other publications like Scaling Biotech. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Scaling Biotech?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.